Current Report Filing (8-k)
03 Setembro 2013 - 6:29PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 15, 2013
Health Insurance Innovations, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
001-35811 |
|
46-1282634 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
|
|
|
15438 N. Florida Avenue, Suite 201
Tampa, Florida |
|
33613 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone number, including area code: (877) 376-5831
Not Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
On August 15, 2013, Michael D. Hershberger, the Chief Financial
Officer, Treasurer and Secretary of Health Insurance Innovations, Inc., a Delaware corporation (the Company), entered into a prearranged trading plan (the Plan) under Rule 10b5-1 of the Securities and Exchange Act of 1934, as
amended (Rule 10b5-1). The Plan provides for the sale of up to 36,000 shares of the Companys stock over a period of time beginning on October 15, 2013 and ending October 2, 2014. Under the Plan, a brokerage firm will be
authorized to sell a certain number of shares of the Companys stock periodically.
The Plan is intended to comply with Rule 10b5-1
and the Companys insider trading policy. Rule 10b5-1 permits officers and directors of public companies to adopt predetermined trading plans for selling specified amounts of stock. The Plan contains certain pre-determined minimum price
conditions in order for trading to occur. The Plan provides for sales to be spread out over a prescribed period of time with the goals of gradually diversifying Mr. Hershbergers investment portfolio while limiting the market impact from
such stock sales.
Transactions under the Plan will be disclosed publicly through Form 4 filings with the Securities and Exchange
Commission, to the extent required by law.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
HEALTH INSURANCE INNOVATIONS, INC. |
|
|
By: |
|
/s/ Michael W. Kosloske |
|
|
Name: |
|
Michael W. Kosloske |
|
|
Title: |
|
Chairman, President and Chief Executive Officer |
Date: September 3, 2013
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024